<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38347167</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1759-5037</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Nature reviews. Endocrinology</Title><ISOAbbreviation>Nat Rev Endocrinol</ISOAbbreviation></Journal><ArticleTitle>Thyroid dysfunction in COVID-19.</ArticleTitle><Pagination><StartPage>336</StartPage><EndPage>348</EndPage><MedlinePgn>336-348</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41574-023-00946-w</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has affected over 772 million people globally. While lung damage is the major contributor to the morbidity and mortality of this disease, the involvement of multiple organs, including the endocrine glands, has been reported. This Review aims to provide an updated summary of evidence regarding COVID-19 and thyroid dysfunction, incorporating highlights of recent advances in the field, particularly in relation to long COVID and COVID-19 vaccination. Since subacute thyroiditis following COVID-19 was first reported in May 2020, thyroid dysfunction associated with COVID-19 has been increasingly recognized, secondary to direct and indirect effects on the hypothalamic-pituitary-thyroid axis. Here, we summarize the epidemiological evidence, pattern and clinical course of thyroid dysfunction following COVID-19 and examine radiological, molecular and histological evidence of thyroid involvement in SARS-CoV-2 infection. Beyond acute SARS-CoV-2 infection, it is also timely to examine the course and implication of thyroid dysfunction in the context of long COVID owing to the large population of survivors of COVID-19 worldwide. This Review also analyses the latest evidence on the relationship between the therapeutics and vaccination for COVID-19 and thyroid dysfunction. To conclude, evidence-based practice recommendations for thyroid function testing during and following COVID-19 and concerning COVID-19 vaccination are proposed.</AbstractText><CopyrightInformation>&#xa9; 2024. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lui</LastName><ForeName>David Tak Wai</ForeName><Initials>DTW</Initials><Identifier Source="ORCID">0000-0002-9813-1126</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chi Ho</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woo</LastName><ForeName>Yu Cho</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hung</LastName><ForeName>Ivan Fan Ngai</ForeName><Initials>IFN</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Karen Siu Ling</ForeName><Initials>KSL</Initials><Identifier Source="ORCID">0000-0001-5757-541X</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. ksllam@hku.hk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Rev Endocrinol</MedlineTA><NlmUniqueID>101500078</NlmUniqueID><ISSNLinking>1759-5029</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013959" MajorTopicYN="Y">Thyroid Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013961" MajorTopicYN="N">Thyroid Gland</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>11</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>13</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>12</Day><Hour>23</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38347167</ArticleId><ArticleId IdType="doi">10.1038/s41574-023-00946-w</ArticleId><ArticleId IdType="pii">10.1038/s41574-023-00946-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO COVID-19 dashboard. WHO https://covid19.who.int (2023).</Citation></Reference><Reference><Citation>Hu, B., Guo, H., Zhou, P. &amp; Shi, Z.-L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 19, 141&#x2013;154 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33024307</ArticleId><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmaeilzadeh, A., Elahi, R., Siahmansouri, A., Maleki, A. J. &amp; Moradi, A. Endocrine and metabolic complications of COVID-19: lessons learned and future prospects. J. Mol. Endocrinol. 69, R125&#x2013;R150 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35900847</ArticleId><ArticleId IdType="doi">10.1530/JME-22-0036</ArticleId></ArticleIdList></Reference><Reference><Citation>Brancatella, A. et al. Subacute thyroiditis after Sars-COV-2 infection. J. Clin. Endocrinol. Metab. 105, dgaa276 (2020). This is the very first case of SAT related to COVID-19 reported in the literature.</Citation><ArticleIdList><ArticleId IdType="pubmed">32436948</ArticleId><ArticleId IdType="doi">10.1210/clinem/dgaa276</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei, L. et al. Pathology of the thyroid in severe acute respiratory syndrome. Hum. Pathol. 38, 95&#x2013;102 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">16996569</ArticleId><ArticleId IdType="doi">10.1016/j.humpath.2006.06.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock, C. et al. SARS-CoV-2 infection and its effects on the endocrine system. Best Pract. Res. Clin. Endocrinol. Metab. 37, 101761 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36907787</ArticleId><ArticleId IdType="doi">10.1016/j.beem.2023.101761</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, H. E., McCorkell, L., Vogel, J. M. &amp; Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133&#x2013;146 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36639608</ArticleId><ArticleId IdType="pmc">9839201</ArticleId><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Meftah, E. et al. Subacute thyroiditis following COVID-19: a systematic review. Front. Endocrinol. 14, 1126637 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2023.1126637</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziaka, M. &amp; Exadaktylos, A. Insights into SARS-CoV-2-associated subacute thyroiditis: from infection to vaccine. Virol. J. 20, 132 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37344878</ArticleId><ArticleId IdType="pmc">10283227</ArticleId><ArticleId IdType="doi">10.1186/s12985-023-02103-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathews, S. E. et al. Subacute thyroiditis and heart failure in a patient presenting with COVID-19. J. Investig. Med. High Impact Case Rep. 9, 23247096211009412 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33853424</ArticleId><ArticleId IdType="pmc">8056563</ArticleId></ArticleIdList></Reference><Reference><Citation>Houshmand, G., Ghorashi, S. M., Mirrazeghi, F. &amp; Omidi, N. Concomitant active inflammation of myocardium and thyroid, incidental finding in COVID-19 pandemic: a case report. Clin. Case Rep. 9, e04998 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34745619</ArticleId><ArticleId IdType="pmc">8552084</ArticleId><ArticleId IdType="doi">10.1002/ccr3.4998</ArticleId></ArticleIdList></Reference><Reference><Citation>Osorio Mart&#xed;nez, A., Gonz&#xe1;lez-Razo, V. T., Navarro-S&#xe1;nchez, V., Souto Meiri&#xf1;o, C. A. &amp; Ahumada-Ayala, M. SARS-CoV-2-related subacute thyroiditis, myocarditis, and hepatitis after full resolution of COVID-19 serum markers. Am. J. Case Rep. 22, e932321 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34138828</ArticleId><ArticleId IdType="doi">10.12659/AJCR.932321</ArticleId></ArticleIdList></Reference><Reference><Citation>Abreu, R., Miguel, R. &amp; Saieg, M. Subacute (De Quervain) thyroiditis during the COVID-19 pandemic. Cancer Cytopathol. 129, 844&#x2013;846 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33970557</ArticleId><ArticleId IdType="pmc">8239629</ArticleId><ArticleId IdType="doi">10.1002/cncy.22449</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller, I. et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 66, 2019&#x2013;2021 (2020). This study described the unique presentation of SARS-CoV-2-related atypical thyroiditis predominantly in patients with severe COVID-19.</Citation></Reference><Reference><Citation>Stasiak, M., Zawadzka-Starczewska, K. &amp; Lewi&#x144;ski, A. Clinical manifestation of subacute thyroiditis triggered by SARS-CoV-2 infection can be HLA-dependent. Viruses 13, 2447 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34960716</ArticleId><ArticleId IdType="pmc">8707017</ArticleId><ArticleId IdType="doi">10.3390/v13122447</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostan, H. et al. Impact of the COVID-19 pandemic on the incidence, seasonal distribution, and characteristics of subacute thyroiditis. Endocrine 79, 323&#x2013;330 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36129593</ArticleId><ArticleId IdType="doi">10.1007/s12020-022-03197-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Batman, A. et al. Subacute THYROiditis related to SARS-CoV-2 vaccine and covid-19 (THYROVAC Study): a Multicenter Nationwide Study. J. Clin. Endocrinol. Metab. 108, 1013&#x2013;1026 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgad235</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Higuera L&#xf3;pez-Fr&#xed;as, M., Perdomo, C. M. &amp; Galofr&#xe9;, J. C. Subacute thyroiditis following COVID-19 infection. Rev. Clin. Esp. 221, 370&#x2013;372 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34059237</ArticleId><ArticleId IdType="pmc">7862888</ArticleId></ArticleIdList></Reference><Reference><Citation>San Juan, M. D. J., Florencio, M. Q. V. &amp; Joven, M. H. Subacute thyroiditis in a patient with coronavirus disease 2019. AACE Clin. Case Rep. 6, e361&#x2013;e364 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33244504</ArticleId><ArticleId IdType="pmc">7685420</ArticleId><ArticleId IdType="doi">10.4158/ACCR-2020-0524</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirola, I. et al. Incidence of De Quervain&#x2019;s thyroiditis during the COVID-19 pandemic in an area heavily affected by Sars-CoV-2 infection. Endocrine 74, 215&#x2013;218 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34363586</ArticleId><ArticleId IdType="pmc">8349140</ArticleId><ArticleId IdType="doi">10.1007/s12020-021-02841-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Brancatella, A. et al. Subacute thyroiditis during the SARS-CoV-2 pandemic. J. Endocr. Soc. 5, bvab130 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34458656</ArticleId><ArticleId IdType="pmc">8344892</ArticleId><ArticleId IdType="doi">10.1210/jendso/bvab130</ArticleId></ArticleIdList></Reference><Reference><Citation>Bah&#xe7;ecio&#x11f;lu, A. B. et al. Subacute thyroiditis during the COVID-19 pandemic: a prospective study. J. Endocrinol. Invest. 45, 865&#x2013;874 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35023078</ArticleId><ArticleId IdType="pmc">8754549</ArticleId><ArticleId IdType="doi">10.1007/s40618-021-01718-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn, H. Y., Choi, H. S., Ha, S. &amp; Cho, S. W. Incidence of subacute thyroiditis during the COVID-19 pandemic in South Korea using the National Health Insurance Service Database. Thyroid 32, 1299&#x2013;1306 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36047822</ArticleId><ArticleId IdType="doi">10.1089/thy.2022.0363</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal, S., DasGupta, R., Lodh, M. &amp; Ganguly, A. Subacute thyroiditis following recovery from COVID-19 infection: novel clinical findings from an Eastern Indian cohort. Postgrad. Med. J. 99, 558&#x2013;565 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2021-141429</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno, S. et al. A case of postpartum thyroiditis following SARS-CoV-2 infection. Endocr. J. 68, 371&#x2013;374 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33177251</ArticleId><ArticleId IdType="doi">10.1507/endocrj.EJ20-0553</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakaizumi, N., Fukata, S., Hirokawa, M. &amp; Akamizu, T. Painless thyroiditis incidentally diagnosed following SARS-CoV-2 infection. BMJ Case Rep. 15, e252837 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36455982</ArticleId><ArticleId IdType="pmc">9716833</ArticleId><ArticleId IdType="doi">10.1136/bcr-2022-252837</ArticleId></ArticleIdList></Reference><Reference><Citation>Fliers, E., Bianco, A. C., Langouche, L. &amp; Boelen, A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 3, 816&#x2013;825 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26071885</ArticleId><ArticleId IdType="pmc">4979220</ArticleId><ArticleId IdType="doi">10.1016/S2213-8587(15)00225-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateu-Salat, M., Urgell, E. &amp; Chico, A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves&#x2019; disease after COVID-19. J. Endocrinol. Invest. 43, 1527&#x2013;1528 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32686042</ArticleId><ArticleId IdType="pmc">7368923</ArticleId><ArticleId IdType="doi">10.1007/s40618-020-01366-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Brancatella, A., Viola, N., Santini, F. &amp; Latrofa, F. COVID-induced thyroid autoimmunity. Best Pract. Res. Clin. Endocrinol. Metab. 37, 101742 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36813660</ArticleId><ArticleId IdType="doi">10.1016/j.beem.2023.101742</ArticleId></ArticleIdList></Reference><Reference><Citation>Allam, M. M., El-Zawawy, H. T., Ahmed, S. M. &amp; Aly Abdelhamid, M. Thyroid disease and covid-19 infection: case series. Clin. Case Rep. 9, e04225 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34178336</ArticleId><ArticleId IdType="pmc">8212015</ArticleId><ArticleId IdType="doi">10.1002/ccr3.4225</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanzolla, G., Marcocci, C. &amp; Marin&#xf2;, M. Graves&#x2019; disease and Graves&#x2019; orbitopathy following COVID-19. J. Endocrinol. Invest. 44, 2011&#x2013;2012 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33964007</ArticleId><ArticleId IdType="pmc">8106371</ArticleId><ArticleId IdType="doi">10.1007/s40618-021-01576-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan, S. Y. T. et al. Acute flaccid tetraparesis after COVID-19 infection: think of the thyroid. Case Rep. Med. 2022, 5827664 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35531575</ArticleId><ArticleId IdType="pmc">9076350</ArticleId><ArticleId IdType="doi">10.1155/2022/5827664</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan, K., Helgeson, J. &amp; McGowan, A. COVID-19 associated thyroid storm: a case report. Clin. Pract. Cases Emerg. Med. 5, 412&#x2013;414 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34813431</ArticleId><ArticleId IdType="pmc">8610451</ArticleId><ArticleId IdType="doi">10.5811/cpcem.2021.5.52692</ArticleId></ArticleIdList></Reference><Reference><Citation>Barajas Galindo, D. E. et al. Increased incidence of Graves&#x2019; disease during the SARS-CoV2 pandemic. Clin. Endocrinol. 98, 730&#x2013;737 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.14860</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaja, M. et al. Hashimoto&#x2019;s thyroiditis encephalopathy induced by COVID-19 infection. Cureus 14, e28419 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36176821</ArticleId><ArticleId IdType="pmc">9509523</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit, N. M. et al. Sudden cardiac arrest in a patient with myxedema coma and COVID-19. J. Endocr. Soc. 4, bvaa130 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32984743</ArticleId><ArticleId IdType="pmc">7499619</ArticleId><ArticleId IdType="doi">10.1210/jendso/bvaa130</ArticleId></ArticleIdList></Reference><Reference><Citation>Darvishi, M., Nazer, M. R., Shahali, H. &amp; Nouri, M. Association of thyroid dysfunction and COVID-19: a systematic review and meta-analysis. Front. Endocrinol. 13, 947594 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.947594</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui, D. T. W. et al. Thyroid dysfunction in relation to immune profile, disease status and outcome in 191 patients with COVID-19. J. Clin. Endocrinol. Metab. 106, 926&#x2013;935 (2021). This cohort study of patients with COVID-19 demonstrates the three common patterns of abnormal thyroid function tests in the context of COVID-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa813</ArticleId></ArticleIdList></Reference><Reference><Citation>Croce, L. et al. The cytokine storm and thyroid hormone changes in COVID-19. J. Endocrinol. Invest. 44, 891&#x2013;904 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33559848</ArticleId><ArticleId IdType="pmc">7871522</ArticleId><ArticleId IdType="doi">10.1007/s40618-021-01506-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldelli, R. et al. Thyroid dysfunction in COVID-19 patients. J. Endocrinol. Invest. 44, 2735&#x2013;2739 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34101132</ArticleId><ArticleId IdType="pmc">8185485</ArticleId><ArticleId IdType="doi">10.1007/s40618-021-01599-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilera, V. et al. Correlation between inflammatory parameters and pituitary-thyroid axis in patients with COVID-19. Endocrine 74, 455&#x2013;460 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34515958</ArticleId><ArticleId IdType="pmc">8436010</ArticleId><ArticleId IdType="doi">10.1007/s12020-021-02863-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Duntas, L. H. &amp; Jonklaas, J. COVID-19 and thyroid diseases: a bidirectional impact. J. Endocr. Soc. 5, bvab076 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34189381</ArticleId><ArticleId IdType="pmc">8135350</ArticleId><ArticleId IdType="doi">10.1210/jendso/bvab076</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoye, C. et al. Is non-thyroidal illness syndrome (NTIS) a clinical predictor of COVID-19 mortality in critically ill oldest old patients? J. Endocrinol. Invest. 45, 1689&#x2013;1692 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35545741</ArticleId><ArticleId IdType="pmc">9094134</ArticleId><ArticleId IdType="doi">10.1007/s40618-022-01806-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Lania, A. et al. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur. J. Endocrinol. 183, 381&#x2013;387 (2020). This cohort study demonstrates the occurrence of thyrotoxicosis without underlying thyroid autoimmunity in the context of COVID-19.</Citation><ArticleIdList><ArticleId IdType="pubmed">32698147</ArticleId><ArticleId IdType="pmc">9494315</ArticleId><ArticleId IdType="doi">10.1530/EJE-20-0335</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparano, C. et al. Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease. J. Endocrinol. Invest. 45, 837&#x2013;847 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34850365</ArticleId><ArticleId IdType="pmc">8632565</ArticleId><ArticleId IdType="doi">10.1007/s40618-021-01714-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Das, L. et al. Spectrum of endocrine dysfunction and association with disease severity in patients with COVID-19: insights from a cross-sectional, observational study. Front. Endocrinol. 12, 645787 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.645787</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzocaro, A. et al. Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study. Endocrine 73, 255&#x2013;260 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34047879</ArticleId><ArticleId IdType="pmc">8161706</ArticleId><ArticleId IdType="doi">10.1007/s12020-021-02758-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Assimakopoulos, S. F. et al. Low serum TSH in the acute phase of COVID-19 pneumonia: thyrotoxicosis or a face of &#x2018;non-thyroidal illness syndrome&#x2019;? Clin. Chem. Lab. Med. 59, e420&#x2013;e423 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34246200</ArticleId><ArticleId IdType="doi">10.1515/cclm-2021-0511</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltr&#xe3;o, F. E. et al. Thyroid hormone levels during hospital admission inform disease severity and mortality in COVID-19 patients. Thyroid 31, 1639&#x2013;1649 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34314259</ArticleId><ArticleId IdType="doi">10.1089/thy.2021.0225</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15a;wi&#x105;tkowska-Stodulska, R., Berli&#x144;ska, A. &amp; Puchalska-Regli&#x144;ska, E. Thyroglobulin levels in COVID-19-positive patients: correlations with thyroid function tests, inflammatory markers, and glucocorticoid use. Front. Endocrinol. 13, 1031188 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.1031188</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliadi, D. A. et al. Thyroid hormone alterations in critically and non-critically ill patients with SARS-CoV-2 infection. Endocr. Connect. 10, 646&#x2013;655 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34010152</ArticleId><ArticleId IdType="pmc">8240704</ArticleId><ArticleId IdType="doi">10.1530/EC-21-0029</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui, D. T. W. et al. Role of non-thyroidal illness syndrome in predicting adverse outcomes in COVID-19 patients predominantly of mild-to-moderate severity. Clin. Endocrinol. 95, 469&#x2013;477 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.14476</ArticleId></ArticleIdList></Reference><Reference><Citation>Akkoyunlu, Y. et al. Analysis of the involvement of the thyroid gland using computed tomography in patients with suspected SARS-CoV-2 infection: a retrospective study. Eur. Rev. Med. Pharmacol. Sci. 25, 4149&#x2013;4155 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34156696</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui, D. T. W. et al. Higher SARS-CoV-2 viral loads correlated with smaller thyroid volumes on ultrasound among male COVID-19 survivors. Endocrine 74, 205&#x2013;214 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34467467</ArticleId><ArticleId IdType="pmc">8408037</ArticleId><ArticleId IdType="doi">10.1007/s12020-021-02855-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Urhan, E., Karaca, Z., Kara, C. S., Yuce, Z. T. &amp; Unluhizarci, K. The potential impact of COVID-19 on thyroid gland volumes among COVID-19 survivors. Endocrine 76, 635&#x2013;641 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35239124</ArticleId><ArticleId IdType="pmc">8892112</ArticleId><ArticleId IdType="doi">10.1007/s12020-022-03019-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung, M. H. M. et al. A prospective follow-up of thyroid volume and thyroiditis features on ultrasonography among survivors of predominantly mild to moderate COVID-19. PeerJ 11, e15034 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36949763</ArticleId><ArticleId IdType="pmc">10026714</ArticleId><ArticleId IdType="doi">10.7717/peerj.15034</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke, S. A., Abbara, A. &amp; Dhillo, W. S. Impact of COVID-19 on the endocrine system: a mini-review. Endocrinology 163, bqab203 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34543404</ArticleId><ArticleId IdType="doi">10.1210/endocr/bqab203</ArticleId></ArticleIdList></Reference><Reference><Citation>Piekarska, A. et al. The influence of SARS-CoV-2 infection on the thyroid gland. Biomedicines 11, 614 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36831150</ArticleId><ArticleId IdType="pmc">9953074</ArticleId><ArticleId IdType="doi">10.3390/biomedicines11020614</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, M.-Y., Li, L., Zhang, Y. &amp; Wang, X.-S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. Poverty 9, 45 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32345362</ArticleId><ArticleId IdType="pmc">7186534</ArticleId><ArticleId IdType="doi">10.1186/s40249-020-00662-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotondi, M. et al. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J. Endocrinol. Invest. 44, 1085&#x2013;1090 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33025553</ArticleId><ArticleId IdType="doi">10.1007/s40618-020-01436-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Coperchini, F. et al. Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study. Endocrine 74, 638&#x2013;645 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34224085</ArticleId><ArticleId IdType="pmc">8256224</ArticleId><ArticleId IdType="doi">10.1007/s12020-021-02807-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, D. W. L. et al. Multisystemic cellular tropism of SARS-CoV-2 in autopsies of COVID-19 patients. Cells 10, 1900 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34440669</ArticleId><ArticleId IdType="pmc">8394956</ArticleId><ArticleId IdType="doi">10.3390/cells10081900</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, G.-C. et al. ACE2 and TMPRSS2 immunolocalization and COVID-19-related thyroid disorder. Biology 11, 697 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35625425</ArticleId><ArticleId IdType="pmc">9138641</ArticleId><ArticleId IdType="doi">10.3390/biology11050697</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedo, S. et al. Detection of SARS-CoV-2 infection in thyroid follicular cells from a COVID-19 autopsy series. Eur. Thyroid. J. 11, e220074 (2022). This autopsy series demonstrates the evidence of direct SARS-CoV-2 involvement in the thyroid gland.</Citation><ArticleIdList><ArticleId IdType="pubmed">35900859</ArticleId><ArticleId IdType="pmc">9346336</ArticleId><ArticleId IdType="doi">10.1530/ETJ-22-0074</ArticleId></ArticleIdList></Reference><Reference><Citation>Koehler, V. F. et al. Thyroidal angiotensin-converting enzyme 2 protein expression and thyroid function tests in patients with COVID-19: results from a retrospective case series and a prospective cohort study. Thyroid 33, 177&#x2013;185 (2023). This study of thyroid samples shows the high percentage of thyroidal ACE2 expression in deceased patients who had COVID-19, suggesting the possible mechanism for SARS-CoV-2 involvement in the thyroid gland.</Citation><ArticleIdList><ArticleId IdType="pubmed">36453232</ArticleId><ArticleId IdType="doi">10.1089/thy.2022.0229</ArticleId></ArticleIdList></Reference><Reference><Citation>Poma, A. M. et al. COVID-19 autopsy cases: detection of virus in endocrine tissues. J. Endocrinol. Invest. 45, 209&#x2013;214 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34191258</ArticleId><ArticleId IdType="pmc">8243303</ArticleId><ArticleId IdType="doi">10.1007/s40618-021-01628-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Poma, A. M. et al. Activation of type I and type II interferon signaling in SARS-CoV-2-positive thyroid tissue of patients dying from COVID-19. Thyroid 31, 1766&#x2013;1775 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34541878</ArticleId><ArticleId IdType="doi">10.1089/thy.2021.0345</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakovac, H., Feren&#x10d;i&#x107;, A., Stemberger, C., Mohar Vitezi&#x107;, B. &amp; Cuculi&#x107;, D. Detection of Sars-Cov-2 antigens in thyroid gland showing histopathological features of subacute thyroiditis. Eur. Thyroid. J. 11, e220005 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35166214</ArticleId><ArticleId IdType="pmc">8963172</ArticleId><ArticleId IdType="doi">10.1530/ETJ-22-0005</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellastella, G. et al. Neuroimmunoendocrinology of SARS-CoV 2 infection. Biomedicines 10, 2855 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36359373</ArticleId><ArticleId IdType="pmc">9687863</ArticleId><ArticleId IdType="doi">10.3390/biomedicines10112855</ArticleId></ArticleIdList></Reference><Reference><Citation>Capatina, C., Poiana, C. &amp; Fleseriu, M. Pituitary and SARS CoV-2: an unremitting conundrum. Best Pract. Res. Clin. Endocrinol. Metab. 37, 101752 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36878774</ArticleId><ArticleId IdType="doi">10.1016/j.beem.2023.101752</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Z. et al. Thyroxine changes in COVID-19 pandemic: a systematic review and meta-analysis. Front. Endocrinol. 14, 1089190 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2023.1089190</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldevila, B., Puig-Domingo, M. &amp; Marazuela, M. Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated? Rev. Endocr. Metab. Disord. 23, 137&#x2013;150 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34333732</ArticleId><ArticleId IdType="doi">10.1007/s11154-021-09678-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Scappaticcio, L., Pitoia, F., Esposito, K., Piccardo, A. &amp; Trimboli, P. Impact of COVID-19 on the thyroid gland: an update. Rev. Endocr. Metab. Disord. 22, 803&#x2013;815 (2021). This study is a concise summary of the effect of COVID-19 on the thyroid gland.</Citation><ArticleIdList><ArticleId IdType="pubmed">33241508</ArticleId><ArticleId IdType="doi">10.1007/s11154-020-09615-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Stasiak, M. &amp; Lewi&#x144;ski, A. New aspects in the pathogenesis and management of subacute thyroiditis. Rev. Endocr. Metab. Disord. 22, 1027&#x2013;1039 (2021). This paper is a comprehensive review of various clinical aspects of SAT, including COVID-19-related SAT.</Citation><ArticleIdList><ArticleId IdType="pubmed">33950404</ArticleId><ArticleId IdType="pmc">8096888</ArticleId><ArticleId IdType="doi">10.1007/s11154-021-09648-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Murugan, A. K. &amp; Alzahrani, A. S. SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves&#x2019; disease. Endocrine 73, 243&#x2013;254 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34106438</ArticleId><ArticleId IdType="pmc">8188762</ArticleId><ArticleId IdType="doi">10.1007/s12020-021-02770-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani, A., Vojdani, E. &amp; Kharrazian, D. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front. Immunol. 11, 617089 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33584709</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2020.617089</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonnello, E. et al. Thyroid hormones and platelet activation in COVID-19 patients. J. Endocrinol. Invest. 46, 261&#x2013;269 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36064879</ArticleId><ArticleId IdType="doi">10.1007/s40618-022-01896-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou, R. et al. Euthyroid sick syndrome in patients with COVID-19. Front. Endocrinol. 11, 566439 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.566439</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao, W. et al. Thyroid hormone concentrations in severely or critically ill patients with COVID-19. J. Endocrinol. Invest. 44, 1031&#x2013;1040 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33140379</ArticleId><ArticleId IdType="doi">10.1007/s40618-020-01460-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui, D. T. W., Lee, C. H. &amp; Lam, K. S. L. Letter to the Editor: &#x2019;Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease&#x2019;-prognostic significance of non-thyroidal illness syndrome across the whole spectrum of COVID-19 severity. J. Endocrinol. Invest. 45, 901&#x2013;902 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35023079</ArticleId><ArticleId IdType="pmc">8755511</ArticleId><ArticleId IdType="doi">10.1007/s40618-021-01732-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong, J. et al. Prognostic significance of low TSH concentration in patients with COVID-19 presenting with non-thyroidal illness syndrome. BMC Endocr. Disord. 21, 111 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34044831</ArticleId><ArticleId IdType="pmc">8159017</ArticleId><ArticleId IdType="doi">10.1186/s12902-021-00766-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin, M. et al. The clinical characteristics and outcomes of COVID-19 patients with pre-existing thyroid dysfunction: a Nationwide study. Horm. Metab. Res. 55, 25&#x2013;30 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36328149</ArticleId><ArticleId IdType="doi">10.1055/a-1971-8781</ArticleId></ArticleIdList></Reference><Reference><Citation>Brix, T. H., Heged&#xfc;s, L., Hallas, J. &amp; Lund, L. C. Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism. Lancet Diabetes Endocrinol. 9, 197&#x2013;199 (2021). A key population-based observational study suggesting that patients treated for hypothyroidism and hyperthyroidism who were infected by SARS-CoV-2 did not fare worse than patients without SARS-CoV-2 infection.</Citation><ArticleIdList><ArticleId IdType="pubmed">33617779</ArticleId><ArticleId IdType="pmc">7906640</ArticleId><ArticleId IdType="doi">10.1016/S2213-8587(21)00028-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen, C. et al. SARS-CoV-2 infection in patients with thyroid disease: a cross-sectional study. Ann. Thyroid. 6, 7 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34151187</ArticleId><ArticleId IdType="doi">10.21037/aot-21-8</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gerwen, M. et al. Outcomes of patients with hypothyroidism and COVID-19: a retrospective cohort study. Front. Endocrinol. 11, 565 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.00565</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira, D. N. et al. Hypothyroidism does not lead to worse prognosis in COVID-19: findings from the Brazilian COVID-19 registry. Int. J. Infect. Dis. 116, 319&#x2013;327 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35065257</ArticleId><ArticleId IdType="pmc">8769529</ArticleId><ArticleId IdType="doi">10.1016/j.ijid.2022.01.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogojevic, M. et al. Association of hypothyroidism with outcomes in hospitalized adults with COVID-19: results from the International SCCM Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry.Clin. Endocrinol. https://doi.org/10.1111/cen.14699 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.14699</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagal&#xe0;, V. et al. Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study. J. Endocrinol. Invest. 46, 1891&#x2013;1899 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36967417</ArticleId><ArticleId IdType="doi">10.1007/s40618-023-02048-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui, D. T. W. et al. Development of a prediction score (ThyroCOVID) for identifying abnormal thyroid function in COVID-19 patients. J. Endocrinol. Invest. 45, 2149&#x2013;2156 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35831586</ArticleId><ArticleId IdType="pmc">9281239</ArticleId><ArticleId IdType="doi">10.1007/s40618-022-01854-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke, S. A. et al. Normal adrenal and thyroid function in patients who survive COVID-19 infection. J. Clin. Endocrinol. Metab. 106, 2208&#x2013;2220 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34008009</ArticleId><ArticleId IdType="pmc">8194556</ArticleId><ArticleId IdType="doi">10.1210/clinem/dgab349</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui, D. T. W. et al. Long COVID in patients with mild to moderate disease: do thyroid function and autoimmunity play a role? Endocr. Pract. 27, 894&#x2013;902 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34237471</ArticleId><ArticleId IdType="pmc">8257401</ArticleId><ArticleId IdType="doi">10.1016/j.eprac.2021.06.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui, D. T. W. et al. A prospective follow-up on thyroid function, thyroid autoimmunity and long COVID among 250 COVID-19 survivors. Endocrine 80, 380&#x2013;391 (2023). A 6-month prospective follow-up study predominantly of patients with non-severe COVID-19 showing that COVID-19 did not lead to a substantial increase in incidence of thyroid dysfunction and thyroid autoimmunity.</Citation><ArticleIdList><ArticleId IdType="pubmed">36596904</ArticleId><ArticleId IdType="pmc">9810240</ArticleId><ArticleId IdType="doi">10.1007/s12020-022-03281-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoo, B. et al. Thyroid function before, during, and after COVID-19. J. Clin. Endocrinol. Metab. 106, e803&#x2013;e811 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33180932</ArticleId><ArticleId IdType="doi">10.1210/clinem/dgaa830</ArticleId></ArticleIdList></Reference><Reference><Citation>Campi, I. et al. The spectrum of thyroid function tests during hospitalization for SARS COV-2 infection. Eur. J. Endocrinol. 184, 699&#x2013;709 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33683214</ArticleId><ArticleId IdType="pmc">9494333</ArticleId><ArticleId IdType="doi">10.1530/EJE-20-1391</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal, A., Gupta, Y., Kalaivani, M. &amp; Tandon, N. Mild and asymptomatic SARS-CoV-2 infection is not associated with progression of thyroid dysfunction or thyroid autoimmunity. Clin. Endocrinol. 5, 7&#x2013;9 (2022).</Citation></Reference><Reference><Citation>Lui, D. T. W. et al. The impact of interferon Beta-1b therapy on thyroid function and autoimmunity among COVID-19 survivors. Front. Endocrinol. 12, 746602 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.746602</ArticleId></ArticleIdList></Reference><Reference><Citation>Alphan Uc, Z., Yagc&#x131;, P., Adibelli, Z. &amp; Duran, C. The spectrum of thyroid function tests and autoantibodies during hospitalization and after six months of discharge in COVID-19 patients: does COVID-19 trigger autoimmunity? Endocr. Res. 48, 44&#x2013;54 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36883908</ArticleId><ArticleId IdType="doi">10.1080/07435800.2023.2188086</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller, I. et al. Long-term outcome of thyroid abnormalities in patients with severe Covid-19. Eur. Thyroid. J. 12, e220200 (2023). A prospective 12-month follow-up study predominantly of patients with severe COVID-19, which showed that all participants had normal thyroid function and normalization of levels of C-reactive protein upon follow-up.</Citation><ArticleIdList><ArticleId IdType="pubmed">36715690</ArticleId><ArticleId IdType="pmc">10083670</ArticleId><ArticleId IdType="doi">10.1530/ETJ-22-0200</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, J., Seo, G. H. &amp; Song, K. Beyond acute COVID-19: investigating the incidence of subacute thyroiditis in long COVID-19 in Korea. Endocrinol. Metab. 38, 455&#x2013;461 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.3803/EnM.2023.1711</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisco, G. et al. Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects. J. Endocrinol. Invest. 44, 1801&#x2013;1814 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33765288</ArticleId><ArticleId IdType="pmc">7992516</ArticleId><ArticleId IdType="doi">10.1007/s40618-021-01554-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Koulouri, O., Moran, C., Halsall, D., Chatterjee, K. &amp; Gurnell, M. Pitfalls in the measurement and interpretation of thyroid function tests. Best Pract. Res. Clin. Endocrinol. Metab. 27, 745&#x2013;762 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24275187</ArticleId><ArticleId IdType="pmc">3857600</ArticleId><ArticleId IdType="doi">10.1016/j.beem.2013.10.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung, I. F. N. Treatment of coronavirus disease 2019. Curr. Opin. HIV AIDS 15, 336&#x2013;340 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33002954</ArticleId><ArticleId IdType="doi">10.1097/COH.0000000000000652</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortajada, C., A&#xf1;&#xf3;n, S., Ortiz, M. M., Andreu-Ballester, J. C. &amp; Flores, J. Interferon &#x3b2;-1b for patients with moderate to severe COVID-19 in the inflammatory phase of the disease. J. Med. Virol. 93, 4102&#x2013;4107 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33856708</ArticleId><ArticleId IdType="pmc">8251165</ArticleId><ArticleId IdType="doi">10.1002/jmv.26976</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15e;endur, S. N., O&#x11f;uz, S. H. &amp; &#xdc;nl&#xfc;t&#xfc;rk, U. COVID-19 vaccination and thyroiditis. Best Pract. Res. Clin. Endocrinol. Metab. 37, 101759 (2023). A comprehensive review of the latest evidence on thyroiditis in relation to COVID-19 vaccination.</Citation><ArticleIdList><ArticleId IdType="pubmed">36933997</ArticleId><ArticleId IdType="doi">10.1016/j.beem.2023.101759</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafyllidis, K. K., Giannos, P., Stathi, D. &amp; Kechagias, K. S. Graves&#x2019; disease following vaccination against SARS-CoV-2: a systematic review of the reported cases. Front. Endocrinol. 13, 938001 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.938001</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, K., Gao, Y. &amp; Li, J. New-onset and relapsed Graves&#x2019; disease following COVID-19 vaccination: a comprehensive review of reported cases. Eur. J. Med. Res. 28, 232 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37443067</ArticleId><ArticleId IdType="pmc">10339579</ArticleId><ArticleId IdType="doi">10.1186/s40001-023-01210-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Watad, A., David, P., Brown, S. &amp; Shoenfeld, Y. Autoimmune/inflammatory syndrome induced by adjuvants and thyroid autoimmunity. Front. Endocrinol. 7, 150 (2016).</Citation></Reference><Reference><Citation>&#x15e;endur, S. N. et al. Association of human leukocyte antigen genotypes with severe acute respiratory syndrome coronavirus 2 vaccine-induced subacute thyroiditis. Thyroid 32, 640&#x2013;647 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35387473</ArticleId><ArticleId IdType="doi">10.1089/thy.2022.0010</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyriacou, A., Ioakim, S. &amp; Syed, A. A. COVID-19 vaccination and a severe pain in the neck. Eur. J. Intern. Med. 94, 95&#x2013;96 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34690055</ArticleId><ArticleId IdType="pmc">8520862</ArticleId><ArticleId IdType="doi">10.1016/j.ejim.2021.10.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ippolito, S. et al. SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review. J. Endocrinol. Invest. 45, 1189&#x2013;1200 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35094372</ArticleId><ArticleId IdType="pmc">8800554</ArticleId><ArticleId IdType="doi">10.1007/s40618-022-01747-0</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo, L. et al. Distinct clinical features of post-COVID-19 vaccination early-onset graves&#x2019; disease. J. Clin. Endocrinol. Metab. 108, 107&#x2013;113 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36130234</ArticleId><ArticleId IdType="doi">10.1210/clinem/dgac550</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, C. K. H. et al. Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients. BMC Med. 20, 339 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36229814</ArticleId><ArticleId IdType="pmc">9560718</ArticleId><ArticleId IdType="doi">10.1186/s12916-022-02548-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui, D. T. W. et al. Effect of COVID-19 vaccines on thyroid function and autoimmunity and effect of thyroid autoimmunity on antibody response. J. Clin. Endocrinol. Metab. 107, e3781&#x2013;e3789 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35679093</ArticleId><ArticleId IdType="doi">10.1210/clinem/dgac355</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorshtein, A., Turjeman, A., Duskin-Bitan, H., Leibovici, L. &amp; Robenshtok, E. Graves&#x2019; disease following COVID-19 vaccination: a population-based, matched case-control study. J. Clin. Endocrinol. Metab. 109, e508&#x2013;e512 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgad582</ArticleId></ArticleIdList></Reference><Reference><Citation>Endo, M. et al. The incidence of Graves&#x2019; hyperthyroidism before and after COVID-19 messenger RNA vaccination. Endocr. Pract. 29, 618&#x2013;622 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37391042</ArticleId><ArticleId IdType="doi">10.1016/j.eprac.2023.05.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, C. H. et al. Effect of inactivated and mRNA COVID-19 vaccination on thyroid function among patients treated for hyperthyroidism. J. Clin. Endocrinol. Metab. 108, e76&#x2013;e88 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36453154</ArticleId><ArticleId IdType="doi">10.1210/clinem/dgac684</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, S. et al. Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of Graves&#x2019; disease: an observational cohort study. Vaccine 41, 5648&#x2013;5654 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37544826</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2023.07.053</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong, X. et al. Safety of inactivated and mRNA COVID-19 vaccination among patients treated for hypothyroidism: a population-based cohort study. Thyroid 32, 505&#x2013;514 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35216517</ArticleId><ArticleId IdType="doi">10.1089/thy.2021.0684</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x11f;uz, S. H. et al. SARS-CoV-2 vaccine-induced thyroiditis: safety of revaccinations and clinical follow-up. J. Clin. Endocrinol. Metab. 107, e1823&#x2013;e1834 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35100622</ArticleId><ArticleId IdType="doi">10.1210/clinem/dgac049</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee, Y. J. et al. SARS-CoV-2 mRNA vaccination and Graves&#x2019; disease: a report of 12 cases and review of the literature. J. Clin. Endocrinol. Metab. 107, 2324&#x2013;2330 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgac119</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossetti, C. L. et al. COVID-19 and thyroid function: what do we know so far? Front. Endocrinol. 13, 1041676 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.1041676</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, M., Zhou, W. &amp; Xu, W. Thyroid function analysis in 50 patients with COVID-19: a retrospective study. Thyroid 31, 8&#x2013;11 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32600165</ArticleId><ArticleId IdType="doi">10.1089/thy.2020.0363</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health. Clinical spectrum of SARS-CoV-2 infection. NIH https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum (2023).</Citation></Reference><Reference><Citation>Pal, R. et al. Endocrine follow-up during post-acute COVID-19: practical recommendations based on available clinical evidence. Endocr. Pract. 28, 425&#x2013;432 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35158058</ArticleId><ArticleId IdType="pmc">8832848</ArticleId><ArticleId IdType="doi">10.1016/j.eprac.2022.02.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku, C. R. et al. COVID-19 vaccination for endocrine patients: a position statement from the Korean Endocrine Society. Endocrinol. Metab. 36, 757&#x2013;765 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3803/EnM.2021.404</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>